Delivery Order SPE2DB20D9759-SPE2DB24FD5MT
Award Date
9/4/24
Potential Completion Date
9/25/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,633.32 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Lucentis 0.5 mg/0.05 ml syringes, which are used to treat various medical conditions. The contract has an ultimate completion date of August 9, 2024 and does not have a set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,155.24 contract is for the supply of Lucentis 0.3 mg/0.05 ml syringes to fulfill the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the supply of the pharmaceutical product Lucentis 0.5 mg/0.05 ml syringe 0.05 ml. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,861.10, is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period through May 29, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $4,510.28 contract is for the supply of 0.3 mg/0.05 ml Lucentis syringes. The order has a completion date of June 3, 2025. DMS Pharmaceutical Group is a pharmaceutical wholesaler that specializes in providing a range of medical products, including prescription drugs, biologics, and consumables, to federal agencies. The company holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,544.44 firm fixed-price delivery order is for the supply of LUCENTIS 0.5 MG/0.05 ML syringes, with a completion date of October 8, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the purchase of LUCENTIS 0.3 MG/0.05 ML SYRING 0.05ML. The contract has a completion date of February 16, 2024 and a potential value of $15,178.80. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic prescription drugs, medical supplies, and other...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $1,544.44 firm fixed-price contract is for the supply of LUCENTIS 0.5 MG/0.05ML, a prescription drug, to support the medical needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.88 contract will provide LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML medical supplies to support the recurring pharmaceutical needs of military health facilities under the DLA's Medical Supply Chain division. This delivery order is part of a larger $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $15,444.40 contract is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product, by March 12, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the DLA, valued up to $4,999,999 through 2025, to provide a wide range of...